Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6427010rdf:typepubmed:Citationlld:pubmed
pubmed-article:6427010lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:6427010lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:6427010lifeskim:mentionsumls-concept:C0024419lld:lifeskim
pubmed-article:6427010lifeskim:mentionsumls-concept:C0032594lld:lifeskim
pubmed-article:6427010lifeskim:mentionsumls-concept:C1441547lld:lifeskim
pubmed-article:6427010lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:6427010lifeskim:mentionsumls-concept:C0205164lld:lifeskim
pubmed-article:6427010lifeskim:mentionsumls-concept:C2825348lld:lifeskim
pubmed-article:6427010lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:6427010lifeskim:mentionsumls-concept:C0067736lld:lifeskim
pubmed-article:6427010pubmed:issue2lld:pubmed
pubmed-article:6427010pubmed:dateCreated1984-7-18lld:pubmed
pubmed-article:6427010pubmed:abstractTextThe carbohydrate chains of the pathological human immunoglobulins M from two patients with Waldenström's macroglobulinemia were released by hydrazinolysis. The N-acetyllactosamine-type glycans were obtained by affinity chromatography on concanavalin A and fractionated by high-voltage paper electrophoresis. The primary structure of the major compounds was elucidated on the basis of carbohydrate analysis, methylation analysis, including mass-spectrometry, and 500 MHz 1H-NMR spectroscopy. For both patients, this appeared to be a monosialyl monofucosyl biantennary structure; the compounds differed by the presence of an intersecting N-acetylglucosamine residue.lld:pubmed
pubmed-article:6427010pubmed:languageenglld:pubmed
pubmed-article:6427010pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6427010pubmed:citationSubsetIMlld:pubmed
pubmed-article:6427010pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6427010pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6427010pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6427010pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6427010pubmed:statusMEDLINElld:pubmed
pubmed-article:6427010pubmed:monthMaylld:pubmed
pubmed-article:6427010pubmed:issn0014-5793lld:pubmed
pubmed-article:6427010pubmed:authorpubmed-author:MontreuilJJlld:pubmed
pubmed-article:6427010pubmed:authorpubmed-author:VliegenthartJ...lld:pubmed
pubmed-article:6427010pubmed:authorpubmed-author:HartmannLLlld:pubmed
pubmed-article:6427010pubmed:authorpubmed-author:CahourAAlld:pubmed
pubmed-article:6427010pubmed:authorpubmed-author:DebeirePPlld:pubmed
pubmed-article:6427010pubmed:authorpubmed-author:van HalbeekHHlld:pubmed
pubmed-article:6427010pubmed:issnTypePrintlld:pubmed
pubmed-article:6427010pubmed:day21lld:pubmed
pubmed-article:6427010pubmed:volume170lld:pubmed
pubmed-article:6427010pubmed:ownerNLMlld:pubmed
pubmed-article:6427010pubmed:authorsCompleteYlld:pubmed
pubmed-article:6427010pubmed:pagination343-9lld:pubmed
pubmed-article:6427010pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6427010pubmed:meshHeadingpubmed-meshheading:6427010-...lld:pubmed
pubmed-article:6427010pubmed:meshHeadingpubmed-meshheading:6427010-...lld:pubmed
pubmed-article:6427010pubmed:meshHeadingpubmed-meshheading:6427010-...lld:pubmed
pubmed-article:6427010pubmed:meshHeadingpubmed-meshheading:6427010-...lld:pubmed
pubmed-article:6427010pubmed:meshHeadingpubmed-meshheading:6427010-...lld:pubmed
pubmed-article:6427010pubmed:meshHeadingpubmed-meshheading:6427010-...lld:pubmed
pubmed-article:6427010pubmed:meshHeadingpubmed-meshheading:6427010-...lld:pubmed
pubmed-article:6427010pubmed:meshHeadingpubmed-meshheading:6427010-...lld:pubmed
pubmed-article:6427010pubmed:meshHeadingpubmed-meshheading:6427010-...lld:pubmed
pubmed-article:6427010pubmed:meshHeadingpubmed-meshheading:6427010-...lld:pubmed
pubmed-article:6427010pubmed:meshHeadingpubmed-meshheading:6427010-...lld:pubmed
pubmed-article:6427010pubmed:year1984lld:pubmed
pubmed-article:6427010pubmed:articleTitlePrimary structure of the major glycans of the N-acetyllactosamine type derived from the human immunoglobulins M from two patients with Waldenström's macroglobulinemia.lld:pubmed
pubmed-article:6427010pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6427010pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6427010lld:pubmed